UTHR - United Therapeutics Corporation

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1,598,8001,465,8001,288,500
Cost of Revenue72,70069,000125,900
Gross Profit1,526,1001,396,8001,162,600
Operating Expenses
Research Development147,600245,100242,500
Selling General and Administrative316,800452,700381,300
Non Recurring---
Total Operating Expenses---
Operating Income or Loss1,061,700699,000538,800
Income from Continuing Operations
Total Other Income/Expenses Net2,400350,1004,000
Earnings Before Interest and Taxes1,064,1001,049,100542,800
Interest Expense3,9004,70017,600
Income Before Tax1,060,2001,044,400525,200
Income Tax Expense346,500392,800185,100
Minority Interest---
Net Income From Continuing Ops713,700651,600340,100
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income713,700651,600340,100
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares713,700651,600340,100